Drugs / SPC5002
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07064525 Comparator | Dec 2024 → Dec 2025 overdue | advanced heart failure, diabetes mellitus, essential hypertension, moderate heart failure | Shin Poong Pharmaceutical Co. Ltd. | Enrolling by invitation | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPC5002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07064525 ↗ |